Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice

Molecular Imaging and Biology

Volumn 17, Issue 3, 2015, Pages 355-363

  Kim, Jongho ^a   Horti, Andrew G ^a   Mathews, William B ^a   Pogorelov, Vladimir ^a   Valentine, Heather ^a   Brasic, James R ^a   Holt, Daniel P ^a   Ravert, Hayden T ^a   Dannals, Robert F ^a   Zhou, Luewi ^c   Jedynak, Bruno ^c   Kamiya, Atsushi ^a   Pletnikov, Mikhail V ^a   Wong, Dean F ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Johns Hopkins University   (United States)

Author keywords

Autoradiography; CB1R; D2 3R; Disrupted in schizophrenia 1 (DISC1) gene; mGluR5; nAChR

Indexed keywords

CANNABINOID RECEPTOR; DISC1 PROTEIN, MOUSE; DOPAMINE; GLUTAMINE; LIGAND; NERVE PROTEIN; NICOTINIC RECEPTOR;

ANIMAL; AUTORADIOGRAPHY; BRAIN; C57BL MOUSE; CEREBELLUM; CHEMISTRY; CROSS BREEDING; DIAGNOSTIC IMAGING; GENETICS; HOMEOSTASIS; MALE; METABOLISM; MOUSE; MULTIMODAL IMAGING; MUTATION; NERVE CELL; NEUROIMAGING; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; TRANSGENIC MOUSE;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CEREBELLUM; CROSSES, GENETIC; DOPAMINE; GLUTAMINE; HOMEOSTASIS; LIGANDS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIMODAL IMAGING; MUTATION; NERVE TISSUE PROTEINS; NEUROIMAGING; NEURONS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, CANNABINOID; RECEPTORS, NICOTINIC;

EID: 84939881694     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-014-0786-4     Document Type: Article

References (41)

1. Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13:1161–1169
2. Millar JK, Christie S, Anderson S et al (2001) Genomic structure and localisation within a linkage hotspot of disrupted in schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry 6:173–178
3. Chubb JE, Bradshaw NJ, Soares DC et al (2008) The DISC locus in psychiatric illness. Mol Psychiatry 13:36–64
4. Pletnikov MV, Ayhan Y, Nikolskaia O et al (2008) Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 13:173–186
5. Sawa A, Snyder SH (2002) Schizophrenia: diverse approaches to a complex disease. Science 296:692–695
6. Dal Bo G, St-Gelais F, Danik M et al (2004) Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine. J Neurochem 88:1398–1405
7. Joyce MP, Rayport S (2000) Mesoaccumbens dopamine neuron synapses reconstructed in vitro are glutamatergic. Neuroscience 99(3):445–456
8. Chuhma N, Choi WY, Mingote S et al (2009) Dopamine neuron glutamate cotransmission: frequency-dependent modulation in the mesoventromedial projection. Neuroscience 164:1068–1083
9. Hnasko TS, Chuhma N, Zhang H et al (2010) Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron 65:643–656
10. Stuber GD, Hnasko TS, Britt JP et al (2010) Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J Neurosci 30:8229–8233
11. Houchi H, Babovic D, Pierrefiche O et al (2005) CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology 30:339–349
12. Thanos PK, Gopez V, Delis F et al (2011) Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption. Alcohol Clin Exp Res 35:19–27
13. Mansvelder HD, McGehee DS (2002) Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 53:606–617
14. Strome EM, Jivan S, Doudet DJ (2005) Quantitative in vitro phosphor imaging using [3H] and [18F] radioligands: the effects of chronic desipramine treatment on serotonin 5-HT2 receptors. J Neurosci Methods 141:143–154
15. Farde L, Ehrin E, Eriksson L et al (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci U S A 82:3863–3867
16. Ametamey SM, Kessler LJ, Honer M et al (2006) Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J Nucl Med 47:698–705
17. Horti AG, Fan H, Kuwabara H et al (2006) 11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors. J Nucl Med 47:1689–1696
18. Horti AG, Gao Y, Kuwabara H et al (2010) Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography. Life Sci 86:575–584
19. Farde L, Hall H, Ehrin E, Sedvall G (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231:258–261
20. Wong DF, Wagner HN Jr, Tune LE et al (1986) Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 234:1558–1563
21. Laurelle M, Kegeles L, Abi-Dargham A (2003) Glutamate, dopamine, and schizophrenia from pathophysiology to treatment. Ann N Y Acad Sci 1003:138–158
22. Jaaro-Peled H, Niwa M, Foss CA et al (2013) Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging. Hum Mol Genet 22:1574–1580
23. Kim SJ, Sullivan JM, Wang S et al (2014) Voxelwise lp-ntPET for detecting localized, transient dopamine release of unknown timing: sensitivity analysis and application to cigarette smoking in the PET scanner. Hum Brain Mapp 35:4876–4891
24. Niwa M, Jaaro-Peled H, Tankou S et al (2013) Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 339:335–339
25. Hayashi-Takagi A, Takaki M, Graziane N et al (2010) Disrupted-in-schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci 13:327–332
26. O’Donnell P, Grace AA (1995) Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci 15:3622–3639
27. Corti C, Xuereb JH, Crepaldi L et al (2011) Altered levels of glutamatergic receptors and Na(+)/K(+) ATPase-alpha1 in the prefrontal cortex of subjects with schizophrenia. Schizophr Res 128:7–14
28. Tokunaga M, Seneca N, Shin RM et al (2009) Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic system. J Neurosci 29:1887–1896
29. Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 24(511):421–427
30. Ishikawa M, Okata M, Huang YH et al (2013) Dopamine triggers heterosynaptic plasticity. J Neurosci 33:6759–6765
31. Saito A, Ballinger MD, Pletnikov MV et al (2013) Endocannabinoid system: potential novel targets for treatment of schizophrenia. Neurobiol Dis 53:10–17
32. Pickel VM, Chan J, Kearn CS, Mackie K (2006) Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol 495:299–313
33. Mackie K (2005) Cannabinoid receptor homo- and heterodimerization. Life Sci 77:1667–1673
34. Martin AB, Fernandez-Espejo E, Ferrer B et al (2008) Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology 33:1667–1679
35. Moldrich G, Wenger T (2000) Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides 21:1735–1742
36. Marcellino D, Carriba P, Filip M et al (2008) Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology 54:815–823
37. Wong DF, Kuwabara H, Kim J et al (2013) PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with [18F]AZAN, a radioligand with optimal brain kinetics. J Nucl Med 54:1308–1448
38. Breese CR, Lee MJ, Adams CE et al (2000) Abnormal regulation of high affinity nicotine receptors in subjects with schizophrenia. Neuropsychopharmacology 23:351–364
39. Robinson TE, Becker JB (1985) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157–198
40. Malmberg A, Jerning E, Mohell N (1996) Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites. Eur J Pharmacol 303:123–128
41. Farde L, Eriksson L, Blomquist G et al (1989) Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET–a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9:696–708